SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-299865
Filing Date
2019-11-25
Accepted
2019-11-25 16:15:32
Documents
4
Period of Report
2019-11-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d839895d8k.htm 8-K 32734
2 EX-99.1 d839895dex991.htm EX-99.1 32864
3 GRAPHIC g839895g1126001826492.jpg GRAPHIC 3767
4 GRAPHIC g839895g1126001826632.jpg GRAPHIC 2708
  Complete submission text file 0001193125-19-299865.txt   75940
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 191246310
SIC: 2834 Pharmaceutical Preparations